{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:25:03Z","timestamp":1707524703740},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,26]]},"DOI":"10.7759\/cureus.27281","type":"journal-article","created":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T12:53:36Z","timestamp":1658840016000},"source":"Crossref","is-referenced-by-count":1,"title":["Chronic Pulmonary Aspergillosis During Convalescence From Severe COVID-19 Treated With Oral Itraconazole: A Report of Two Cases"],"prefix":"10.7759","author":[{"given":"Hiroshi","family":"Horiuchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syusuke","family":"Utada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshie","family":"Shinomiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Miyagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azusa","family":"Sogo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoko","family":"Niida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromu","family":"Okano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Furuya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhin.2021.04.012","article-title":"Incidence, diagnosis and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA): a systematic review","volume":"113","author":"Chong WH","year":"2021","unstructured":"Chong WH, Neu KP. Incidence, diagnosis and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA): a systematic review. J Hosp Infect. 2021, 113:115-29. 10.1016\/j.jhin.2021.04.012","journal-title":"J Hosp Infect"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30847-1","article-title":"Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance","volume":"21","author":"Koehler P","year":"2021","unstructured":"Koehler P, Bassetti M, Chakrabarti A, et al.. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis. 2021, 21:e149-62. 10.1016\/S1473-3099(20)30847-1","journal-title":"Lancet Infect Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.2004.01035.x","article-title":"Antibody detection in patients with invasive aspergillosis (Article in German)","volume":"47","author":"Kappe R","year":"2004","unstructured":"Kappe R, Rimek D. Antibody detection in patients with invasive aspergillosis (Article in German). Mycoses. 2004, 47:55-9. 10.1111\/j.1439-0507.2004.01035.x","journal-title":"Mycoses"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.21-0701","article-title":"Case report: chronic cavitatory pulmonary aspergillosis after COVID-19","volume":"106","author":"Chaurasia S","year":"2021","unstructured":"Chaurasia S, Thimmappa M, Chowdhury S. Case report: chronic cavitatory pulmonary aspergillosis after COVID-19. Am J Trop Med Hyg. 2021, 106:105-7. 10.4269\/ajtmh.21-0701","journal-title":"Am J Trop Med Hyg"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1086\/376526","article-title":"Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review","volume":"37","author":"Denning DW","year":"2003","unstructured":"Denning DW, Riniotis K, Dobrashian R, Sambatakou H. Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review. Clin Infect Dis. 2003, 37:S265-80. 10.1086\/376526","journal-title":"Clin Infect Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00583-2015","article-title":"Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management","volume":"47","author":"Denning DW","year":"2016","unstructured":"Denning DW, Cadranel J, Beigelman-Aubry C, et al.. Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management. Eur Respir J. 2016, 47:45-68. 10.1183\/13993003.00583-2015","journal-title":"Eur Respir J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1378\/chest.06-2441","article-title":"Treatment of chronic pulmonary aspergillosis by voriconazole in nonimmunocompromised patients","volume":"131","author":"Camuset J","year":"2007","unstructured":"Camuset J, Nunes H, Dombret MC, et al.. Treatment of chronic pulmonary aspergillosis by voriconazole in nonimmunocompromised patients. Chest. 2007, 131:1435-41. 10.1378\/chest.06-2441","journal-title":"Chest"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2005.11.028","article-title":"Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis","volume":"119","author":"Sambatakou H","year":"2006","unstructured":"Sambatakou H, Dupont B, Lode H, Denning DW. Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis. Am J Med. 2006, 119:527.e17-24. 10.1016\/j.amjmed.2005.11.028","journal-title":"Am J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-012-1690-y","article-title":"Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trial","volume":"31","author":"Cadranel J","year":"2012","unstructured":"Cadranel J, Philippe B, Hennequin C, et al.. Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trial. Eur J Clin Microbiol Infect Dis. 2012, 31:3231-9. 10.1007\/s10096-012-1690-y","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0240374","article-title":"Tolerability of oral itraconazole and voriconazole for the treatment of chronic pulmonary aspergillosis: a systematic review and meta-analysis","volume":"15","author":"Olum R","year":"2020","unstructured":"Olum R, Baluku JB, Kazibwe A, Russell L, Bongomin F. Tolerability of oral itraconazole and voriconazole for the treatment of chronic pulmonary aspergillosis: a systematic review and meta-analysis. PLoS One. 2020, 15:e0240374. 10.1371\/journal.pone.0240374","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson TF","year":"2016","unstructured":"Patterson TF, Thompson GR 3rd, Denning DW, et al.. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016, 63:e1-e60. 10.1093\/cid\/ciw326","journal-title":"Clin Infect Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/myc.13324","article-title":"Anti-fungal agents in the treatment of chronic pulmonary aspergillosis: systematic review and a network meta-analysis","volume":"64","author":"Sehgal IS","year":"2021","unstructured":"Sehgal IS, Dhooria S, Prasad KT, Muthu V, Aggarwal AN, Chakrabarti A, Agarwal R. Anti-fungal agents in the treatment of chronic pulmonary aspergillosis: systematic review and a network meta-analysis. Mycoses. 2021, 64:1053-61. 10.1111\/myc.13324","journal-title":"Mycoses"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0259766","article-title":"Clinical manifestations, associated risk factors and treatment outcomes of chronic pulmonary aspergillosis (CPA): experiences from a tertiary care hospital in Lahore, Pakistan","volume":"16","author":"Akram W","year":"2021","unstructured":"Akram W, Ejaz MB, Mallhi TH, Syed Sulaiman SA, Khan AH. Clinical manifestations, associated risk factors and treatment outcomes of chronic pulmonary aspergillosis (CPA): experiences from a tertiary care hospital in Lahore, Pakistan. PLoS One. 2021, 16:e0259766. 10.1371\/journal.pone.0259766","journal-title":"PLoS One"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-021-00923-4","article-title":"Risk factors for invasive aspergillosis in ICU patients with COVID-19: current insights and new key elements","volume":"11","author":"Montrucchio G","year":"2021","unstructured":"Montrucchio G, Lupia T, Lombardo D, Stroffolini G, Corcione S, De Rosa FG, Brazzi L. Risk factors for invasive aspergillosis in ICU patients with COVID-19: current insights and new key elements. Ann Intensive Care. 2021, 11:136. 10.1186\/s13613-021-00923-4","journal-title":"Ann Intensive Care"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.5812\/ijem.113220","article-title":"A systematic review and meta-analysis of diabetes associated mortality in patients with COVID-19","volume":"19","author":"Gupta P","year":"2021","unstructured":"Gupta P, Gupta M, KAtoch N, Garg K, Garg B. A systematic review and meta-analysis of diabetes associated mortality in patients with COVID-19. Int J Endocrinol Metab. 2021, 19:e113220. 10.5812\/ijem.113220","journal-title":"Int J Endocrinol Metab"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/105736-chronic-pulmonary-aspergillosis-during-convalescence-from-severe-covid-19-treated-with-oral-itraconazole-a-report-of-two-cases","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:36:10Z","timestamp":1707507370000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/105736-chronic-pulmonary-aspergillosis-during-convalescence-from-severe-covid-19-treated-with-oral-itraconazole-a-report-of-two-cases"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,26]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.27281","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,26]]}}}